Rasoulinasab Masoumeh, Shahcheraghi Fereshteh, Feizabadi Mohammad Mehdi, Nikmanesh Bahram, Hajihasani Azade, Aslani Mohammad Mehdi
Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Microbiol. 2021 Jun;13(3):294-302. doi: 10.18502/ijm.v13i3.6389.
sequence type 131 (ST131) is associated with extended-spectrum beta-lactamase (ESBL) production and fluoroquinolone resistance. This study aimed to investigate the prevalence of ST131, ESBL, and plasmid-mediated quinolone resistance (PMQR) genes in the ciprofloxacin-resistant (CIP) and ESBL producers from women with UTI.
The CIP-resistant ESBL producing (CIP/ESBL) isolates were screened for ST131-by specific PCR of and . The ESBL and PMQR genes were screened by single PCR. The ST131 and non-ST131 isolates were selected to determine the mutations of and using PCR and sequencing, and also their genetic background by the Pasteur-MLST scheme.
Overall, 55% (33/60) CIP/ESBL isolates were identified as ST131 (94% O25b-ST131). Resistance rate to ampicillin-sulbactam (70%), aztreonam (97%) and gentamicin (61%), the prevalence of (66%), (82%), the profile of (30%), and the double mutation in the was significantly higher in ST131 than non- ST131 isolates. The coexistence of PMQR and ESBL genes was found in more than 50% of ST131 and non-ST131 isolates. ST131 isolates differentiated into PST43 and PST506.
Management of women with UTI caused by the CIP/ESBL isolates (ST131) co-harbored PMQR, ESBL, and chromosomal mutations, is important for their effective therapy.
131型序列(ST131)与超广谱β-内酰胺酶(ESBL)的产生及氟喹诺酮耐药性相关。本研究旨在调查泌尿道感染女性患者中耐环丙沙星(CIP)及产ESBL菌株的ST131、ESBL和质粒介导喹诺酮耐药(PMQR)基因的流行情况。
通过针对 和 的特异性PCR对耐CIP产ESBL(CIP/ESBL)分离株进行ST131筛查。通过单重PCR筛查ESBL和PMQR基因。选择ST131和非ST131分离株,采用PCR和测序确定 和 的突变情况,并通过巴斯德多位点序列分型方案确定其遗传背景。
总体而言,55%(33/60)的CIP/ESBL分离株被鉴定为ST131(94%为O25b-ST131)。ST131分离株对氨苄西林-舒巴坦(70%)、氨曲南(97%)和庆大霉素(61%)的耐药率、 (66%)、 (82%)的流行率、 的分布情况(30%)以及 中的双重突变均显著高于非ST131分离株。超过50%的ST131和非ST131分离株中发现了PMQR和ESBL基因共存。ST131分离株分为PST43和PST506。
对于由同时携带PMQR、ESBL和染色体突变的CIP/ESBL分离株(ST131)引起的女性泌尿道感染进行管理,对有效治疗至关重要。